IGF2BP1 and carcinoma: An m6A-dependent stimulation of SRF expression by IGF2BP1 has been reported, which was accomplished through disruption of SRF mRNA decay directed by miRNAs, consequently resulting in improved action of SRF-dependent transcription and carcinoma cell proliferation and infiltration (Müller et al., 2018).